Provided by Tiger Trade Technology Pte. Ltd.

Athira Pharma, Inc.

6.75
0.0000
Volume:- -
Turnover:495.51K
Market Cap:26.62M
PE:-0.70
High:6.75
Open:6.75
Low:6.75
Close:6.75
52wk High:8.36
52wk Low:2.20
Shares:3.94M
Float Shares:1.09M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.6552
EPS(LYR):-25.1917
ROE:-89.42%
ROA:-42.21%
PB:0.99
PE(LYR):-0.27

Loading ...

Athira Pharma Inc - Co's Common Stock Will Commence Trading on Nasdaq Capital Market Under New Ticker Symbol on Jan 12

THOMSON REUTERS
·
Jan 09

Athira Pharma Announces Name Change to Leonabio, Inc. With New Ticker “Lona”

THOMSON REUTERS
·
Jan 09

Athira Pharma Changes Name to LeonaBio

Reuters
·
Jan 09

Athira Pharma General Counsel Mark Worthington Reports Disposal of Common Shares

Reuters
·
Jan 06

Sector Update: Health Care Stocks Rise Late Afternoon

MT Newswires Live
·
Dec 19, 2025

Why Is Athira Pharma Stock Spiking After Breast Cancer Asset Acquisition?

Benzinga
·
Dec 19, 2025

Top Midday Gainers

MT Newswires Live
·
Dec 19, 2025

Investors Await Key Inflation, Employment Data as US Futures Rise Thursday Pre-Bell

MT Newswires Live
·
Dec 18, 2025

Athira Pharma Raises $90 Million in Private Placement of Shares and Warrants

Reuters
·
Dec 18, 2025

Athira Pharma- Financing Co-Led by Commodore Capital, Perceptive Advisors, Tcgx, Participation From Adar1 & Others

THOMSON REUTERS
·
Dec 18, 2025

Athira Pharma Inc - Financing to Support Lasofoxifene Development Through 2028

THOMSON REUTERS
·
Dec 18, 2025

Athira Pharma Inc - Announces $90 Mln Financing With Potential $146 Mln More

THOMSON REUTERS
·
Dec 18, 2025

Athira Pharma Announces Exclusive License to Lasofoxifene Phase 3 Development Program for Metastatic Breast Cancer Candidate and a Financing for up to $236 Million

GlobeNewswire
·
Dec 18, 2025

Athena Gold Reports Promising Drilling Results at Excelsior Springs Project

TIPRANKS
·
Nov 26, 2025

Athena Gold Upsizes Private Placement Amid Strong Investor Demand

TIPRANKS
·
Nov 24, 2025

Athena Gold Corporation Reports Increased Assets in Q3 2025

TIPRANKS
·
Nov 21, 2025

Analysts Offer Insights on Healthcare Companies: Athira Pharma (ATHA) and Cartesian Therapeutics (RNAC)

TIPRANKS
·
Nov 17, 2025

Athena Gold Expands Landholding at Excelsior Springs Project

TIPRANKS
·
Nov 11, 2025

Athira Pharma Q3 EPS $(1.68) Misses $(1.20) Estimate

Benzinga
·
Nov 07, 2025

Athira Pharma Q3 net loss narrows, exploring strategic alternatives

Reuters
·
Nov 07, 2025